⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Nalbuphine Versus Morphine for Perioperative Tumor Ablation

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Nalbuphine Versus Morphine for Perioperative Tumor Ablation

Official Title: Analgesic Efficacy and Safety of Nalbuphine Versus Morphine for Perioperative Tumor Ablation: a Randomized, Control, Multicentre Trial

Study ID: NCT05073744

Interventions

Nalbuphine
Morphine

Study Description

Brief Summary: This randomized, positive control, multicentre trial is designed to compare the analgesic efficacy and safety of nalbuphine hydrochloride injection and morphine hydrochloride injection for perioperative tumor ablation.

Detailed Description: Sedation and analgesia use in tumor ablation is a necessary part of the procedure. However, the optimal medicine for sedation and analgesia for tumor ablation remains controversial. Currently, morphine is a traditional opioid used for pain control and anaesthesia. As no publications have compared the anaesthetic and analgesic effects between nalbuphine and morphine during tumor ablation, this trial aims to compare the analgesic efficacy and safety of nalbuphine and morphine for perioperative tumor ablation. In addition, other endpoints in term of perioperative analgesia indexes, such as ablation time, daily dose, analgesia satisfaction, quality of life, and safety, etc. will be compared.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Anhui Province Cancer Hospital, Hefei, Anhui, China

The Second Hospital of Anhui Medical University, Hefei, Anhui, China

The First Hospital of Lanzhou University, Lanzhou, Gansu, China

Guangxi Medical University Affiliated Tumor Hospita, Nanning, Guangxi, China

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China

The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou, China

Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China

Henan Provincial People's Hospital, Zhengzhou, Henan, China

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

Jingmen NO.2People's Hospital, Jingmen, Hubei, China

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China

Yichang Central People's Hospital, Yichang, Hubei, China

The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Zhongda Hospital Southeast University, Nanjing, Jiangsu, China

The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China

The First Bethune Hospital of Jilin University, Changchun, Jilin, China

Shengjing Hospital of China Medical University, Shengyang, Liaoning, China

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China

Shanghai Tenth People's Hospital, Shanghai, Shanghai, China

Lishui Municipal Central Hospital, Lishui, Zhejiang, China

Contact Details

Name: Gao-Jun Teng, MD

Affiliation: Zhongda Hospital

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: